Accessibility Statement

Our Commitment to Accessibility

Cyclacel is committed to making our website accessible to everyone. We have built our website in a manner to work with assistive technologies using the Worldwide Web Consortium’s Website Content Accessibility Guidelines (https://www.w3.org/WAI/standards-guidelines/wcag/). Cyclacel continues to evaluate its website to maintain and expand its accessibility for all visitors.

Feedback

In case of difficulty using or accessing any element of this website or have other questions regarding other reasonable modifications or auxiliary aids, please contact us at

(908) 517-7330 or .

Paul McBarron

Executive Vice President, Chief Financial Officer & Chief Operating Officer​

Mr. McBarron has served as a director of the Company since March 2006. Mr. McBarron joined Cyclacel in January 2002 and has over 30 years of experience with pharmaceutical and biotechnology companies. He has served as a financial executive at Sterling Drug, Sanofi-Winthrop and SmithKline Beecham and, from 1996 to 2001, as a senior member of the finance team at Shire Pharmaceuticals plc, where he held the positions of Director of Corporate Finance and Group Financial Controller. He joined Shire when it was an emerging public company. He qualified as a chartered accountant with Ernst & Young and served on the Scottish Lifesciences Association Board.